Trachoma and trichiasis treatment coverage

Measures 3.8.1 and 3.8.2
The estimated number, and proportion of:
  • Community members who were treated in communities where active trachoma was identified
  • First Nations adults with trichiasis who were treated.

The screening and treatment frequency for trachoma in at-risk communities is based on the trachoma prevalence rate (Figure 46 and Figure 47). Treatment for trichiasis is important for preventing vision loss.

Figure 46: Trachoma treatment coverage, 2011 to 2022

Trachoma treatment coverage, 2011 to 2022

Community members where active trachoma was identified who were treated 2011 to 2022

This dual axis combined line chart and scatter plot shows the percentage and number of active trachoma cases treated between 2011 and 2022. The chart shows that, in this period, the proportion of First Nations people with active trachoma who received treatment rose from 65%, peaking at 90% in 2014 and declining to 71% in 2021 then increasing to 96% in 2022 .

Visualisation not available for printing

The proportion of community members who received treatment for trachoma has generally increased over time from 65% in 2011 to 95% in 2022.

Figure 47: Trachoma treatment coverage: interactive data

Trachoma treatment coverage: interactive data

 

 

There are 2 separate charts for this measure by various characteristics.

Community members where active trachoma was identified who were treated by age, 2022

This dual axis combined vertical bar chart and scatter plot displays the number and percentage of active trachoma cases treated in 2022, by age. The chart shows that a total of 829 First Nations people with active trachoma received treatment for the condition, a rate of 96%. This included 84 children aged 0–4 (94%), 187 aged 5–9 (98%) and 106 aged 10–14 (97%) and 452 Indigenous young Australians and adults aged 15 years and over (93%).

Community members where active trachoma was identified who were treated by jurisdiction, 2022

This dual axis combined vertical bar chart and scatter plot displays the percentage and number of active trachoma cases treated in 2022, by jurisdiction. The chart shows that the proportion of First Nations people with active trachoma who received treatment was 71% in Western Australia (304 people), 97%, and 96% in the Northern Territory (525 people). In SA and Queensland there were no cases with active trachoma.


Visualisation not available for printing
  • In 2022, in communities where active trachoma was identified, a total of 829 community members received treatment, a rate of 95%. This included 84 children aged 0–4 years (94%), 187 aged 5–9 years (98%), 106 aged 10–14 years (97%) and 452 (93%) community members aged 15 years and over.
  • Between 2011 and 2022, in communities where active trachoma was identified, the proportion of community members who received treatment rose from 65% in 2011 to 90% in 2014. The proportion who received treatment generally declined from then to 71% in 2021 before increasing in 2022 to 95%.
  • In 2022, in the 3 jurisdictions with at-risk communities, 4 First Nations adults aged 40 years and over with trichiasis had surgery in the past 12 months. Two of the 4 surgeries took place in Western Australia.
  • Between 2012 and 2022, the number of First Nations adults aged 40 years and over who had surgery for trichiasis rose from 16 adults in 2012 to 31 in 2013. The number of surgeries has generally declined over time since then, to 4 in 2022.